Caribou Biosciences, Inc. (CRBU)

Caribou Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	29.42	16.29	51.16	58.34	240.42	15.95
Short-Term Investments	179.05	193.24	277.67	189.33	135.41	-
Cash & Short-Term Investments	208.47	209.54	328.83	247.66	375.83	15.95
Cash Growth	-29.09%	-36.28%	32.77%	-34.10%	2255.87%	-67.75%
Accounts Receivable	0.9	1.42	1.57	2.45	2.64	1.48
Other Receivables	1.84	1.83	2.29	2.22	5.48	3.68
Receivables	2.74	3.25	3.86	4.66	8.12	5.16
Prepaid Expenses	3.86	4.81	4.94	6.37	3.85	1.82
Other Current Assets	2.26	1.78	1.22	1.55	3.39	1.38
Total Current Assets	217.32	219.38	338.84	260.25	391.19	24.31
Property, Plant & Equipment	38.04	39.29	40.45	34.91	4.89	3.5
Long-Term Investments	13.25	49.13	51.33	77.07	45.3	7.63
Other Long-Term Assets	5.04	5.52	1.59	1.54	0.98	0.61
Total Assets	273.66	313.31	432.21	373.77	442.36	36.05
Accounts Payable	3.87	2.48	3.12	1.15	3.99	2.6
Accrued Expenses	18.34	21.94	19.65	14.41	12.09	8.15
Current Portion of Long-Term Debt	-	-	-	-	-	0.65
Current Portion of Leases	1.9	1.43	1.2	0.97	-	-
Current Unearned Revenue	2.83	3.13	2.85	9.94	8.7	0.16
Other Current Liabilities	1.54	1.68	1.48	1.67	1.05	0.82
Total Current Liabilities	28.49	30.65	28.3	28.13	25.83	12.39
Long-Term Debt	-	-	-	-	-	0.92
Long-Term Leases	24.32	25.06	25.91	26.78	-	0.1
Long-Term Unearned Revenue	2.62	3.32	6.1	15.95	22.03	0.94
Long-Term Deferred Tax Liabilities	0.55	0.55	0.56	0.38	0.48	0.16
Other Long-Term Liabilities	0.45	0.79	2.94	1.65	6.19	3.66
Total Liabilities	56.43	60.36	63.81	72.89	54.53	18.16
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	705.43	701.08	667.65	499.6	485.75	7.43
Retained Earnings	-488.38	-448.39	-299.29	-197.22	-97.79	-30.87
Comprehensive Income & Other	0.17	0.26	0.03	-1.52	-0.14	-
Total Common Equity	217.22	252.95	368.4	300.87	387.83	-23.44
Shareholders' Equity	217.22	252.95	368.4	300.87	387.83	17.89
Total Liabilities & Equity	273.66	313.31	432.21	373.77	442.36	36.05
Total Debt	26.22	26.49	27.11	27.75	-	1.68
Net Cash (Debt)	186.23	222.9	345.3	289.29	413.51	14.28
Net Cash Growth	-41.58%	-35.45%	19.36%	-30.04%	2796.73%	-71.03%
Net Cash Per Share	2.04	2.47	4.68	4.76	13.06	1.67
Filing Date Shares Outstanding	93	93	90.31	61.3	60.66	10.39
Total Common Shares Outstanding	93	92.38	88.45	61.03	60.26	9.71
Working Capital	188.83	188.73	310.54	232.12	365.36	11.92
Book Value Per Share	2.34	2.74	4.17	4.93	6.44	-2.41
Tangible Book Value	217.22	252.95	368.4	300.87	387.83	-23.44
Tangible Book Value Per Share	2.34	2.74	4.17	4.93	6.44	-2.41
Machinery	21.05	20.65	16.98	13.46	7.25	5.42
Construction In Progress	-	-	8.2	0.99	0.01	-
Leasehold Improvements	11.52	11.52	2.24	1.88	1.7	1.18

Updated Mar 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q